GLP-1 Drugs Effective For Weight Loss, Improving HbA1C Levels Among Patients With HIV Infection, Study Finds

Infectious Disease Advisor (5/7, Nye) reports, “Glucagon-like peptide-1 (GLP-1) receptor agonists are associated with weight loss, lower BMI, and improved HbA1C levels among patients with HIV infection, according to study results published in Clinical Infectious Diseases.” In the study, “overall, GLP-1 receptor agonist use was associated with a mean weight loss of 5.4 kg and a mean BMI reduction of 1.8 kg/m2, with 99 (44%) patients experiencing greater than 5% weight loss.”